09:18 AM EST, 11/20/2024 (MT Newswires) -- Health care stocks were edging higher premarket Wednesday as the iShares Biotechnology ETF (IBB) was 0.4% higher and the Health Care Select Sector SPDR Fund ( XLV ) was recently up 0.5%.

Argenx (ARGX) shares were up more than 2% after the company said it will proceed with developing its experimental drug, efgartigimod subcutaneous, to treat idiopathic inflammatory myopathies in its ongoing phase 2/3 study.

SAGE Therapeutics ( SAGE ) shares were down over 5% after the company said its phase 2 DIMENSION study of dalzanemdor in participants with cognitive impairment associated with Huntington's Disease did not meet its primary and secondary endpoints.

Novo Nordisk ( NVO ) has rolled out Wegovy in China to treat adults with obesity and

overweight, a company spokesperson confirmed to MT Newswires in an email. Novo Nordisk ( NVO ) shares were up over 1% premarket.